Low Prevalence of Botulinum Toxin-A Adverse Effects: Good Safety Profile or Underreporting?
Journal: Journal of Novel Physiotherapy and Physical Rehabilitation (Vol.4, No. 4)Publication Date: 2017-11-10
Authors : O.Aimer N.Roche H.Michelon A.Schnitzler K.Hamami L.Fellous F.Genet M.Villart;
Page : 090-093
Keywords : Botulinum toxin type A; spasticity; phar- macovigilance; Adverse effects;
Abstract
Introduction: The incidence of botulinum toxin type A (BoNT-A) injections related adverse effects (AE) is relatively high in literature. Many of injections are carried out yearly in our Physical and Rehabilitation Medicine (PRM) unit, however only 4 adverse effects have been reported since 2010.
The aim of this single-center prospective observational study was to determine the reasons to explain the large difference in the prevalence of AE reported in the literature and in our PRM unit, and to take measures to improve AE reporting.
Other Latest Articles
- Therapy accompanying use of VRglasses in hemiparetic children and adolescents
- Effect of Robotic Assisted Gait Training on functional and psychological improvement in patients with Incomplete Spinal Cord Injury
- The Effects of Whole Body Periodic Acceleration on Non-Motor Symptoms in Persons with Parkinson’s disease: A Pilot Study
- Exercise Tolerance in Children with Simple Congenitally Corrected Transposition of the Great Arteries: A Comparative Study
- Non-surgical Spinal Decompression an Effective Physiotherapy Modality for Neck and Back Pain
Last modified: 2018-09-11 22:27:38